SCHEMBL16332292

SCHEMBL16332292

CNc1nc2cnc(Nc3cc(OC)c(OC)c(OC)c3)cc2n1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 5/20 0.47
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ KDR P35968 3/20 0.43
▸ LCK P06239 2/20 0.43
▸ MAPK14 Q16539 2/20 0.43
▸ IGF1R P08069 3/20 0.42
▸ POLB P06746 1/20 0.42
▸ RAD52 P43351 1/20 0.42
▸ EGFR P00533 2/20 0.41
▸ CDK2 P24941 2/20 0.41
▸ INSR P06213 1/20 0.41
▸ MET P08581 1/20 0.41
▸ TEK Q02763 1/20 0.41
▸ PLK1 P53350 1/20 0.41
▸ PLK3 Q9H4B4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16332185 0.91 PTK2 (0.52) BRAFSMN1; SMN2KDRLCKIGF1R
SCHEMBL16332223 0.90 SMN1; SMN2 (0.44) BRAFCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL16332496 0.86 GABRG2 (0.47) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL16331800 0.86 SMN1; SMN2 (0.44) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL16332134 0.85 SMN1; SMN2 (0.52) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL16331809 0.85 IGF1R (0.42) BRAFSMN1; SMN2KDRIGF1REGFR
SCHEMBL16331960 0.83 CSF1R (0.46) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL16331454 0.83 BRAF (0.49) BRAFKDRLCKMAPK14IGF1R
SCHEMBL16331677 0.82 BRAF (0.45) BRAFKDRLCKMAPK14IGF1R
SCHEMBL16331646 0.81 GABRG2 (0.46) BRAFIGF1REGFRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2818472-A1 Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — EP claimed
EP-2818472-A1 Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — EP disclosed
Send feedback